[A naturalistic study on the effects of antidepressants (e. g. SSRI) and acetyl salicylic acid (ASA) on the self-rated perception of the psychotherapeutic process of inpatient psychosomatic treatment and its results: Could ASA be beneficial?]

IF 0.8 4区 医学 Q4 PSYCHIATRY
Marius Binneböse, Jan Schott, Hannah Wallis, Christian Kaiser, Matthias Vogel
{"title":"[A naturalistic study on the effects of antidepressants (e. g. SSRI) and acetyl salicylic acid (ASA) on the self-rated perception of the psychotherapeutic process of inpatient psychosomatic treatment and its results: Could ASA be beneficial?]","authors":"Marius Binneböse, Jan Schott, Hannah Wallis, Christian Kaiser, Matthias Vogel","doi":"10.13109/zptm.2023.69.4.369","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objectives:</b> Psychic perceptions are at the core of psychotherapeutic processes and modifiable by certain psychopharmacologic agents including antidepressants and cyclooxygenase (COX) inhibitors like acetylsalicylic acid (ASA). <b>Methods:</b> We analyzed the medical records of 208 participants, and used the weekly mean dosages and the number of weeks in therapy to predict ward experience (Stationserfahrungsbogen) and symptom burden (symptom-check list 90-R) by means of linear regression analyses and four repeated measures. <b>Results:</b> Time predicted symptom relief. ASA signified a more favorable ward experience and a trend towards less suffering. Antidepressants did not predict symptom burden or ward experience, except for amitriptyline's inverse relationship with process perception. <b>Discussion:</b> Regarding process perception and therapy outcome, amitriptyline might have unfavorable effects at dose reductions, whereas COX-inhibition could be beneficial at higher dosages. Similar findings have already been described with regard to COX-inhibition in depression and schizophrenia.</p>","PeriodicalId":51217,"journal":{"name":"Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie","volume":"69 4","pages":"369-382"},"PeriodicalIF":0.8000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.13109/zptm.2023.69.4.369","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Psychic perceptions are at the core of psychotherapeutic processes and modifiable by certain psychopharmacologic agents including antidepressants and cyclooxygenase (COX) inhibitors like acetylsalicylic acid (ASA). Methods: We analyzed the medical records of 208 participants, and used the weekly mean dosages and the number of weeks in therapy to predict ward experience (Stationserfahrungsbogen) and symptom burden (symptom-check list 90-R) by means of linear regression analyses and four repeated measures. Results: Time predicted symptom relief. ASA signified a more favorable ward experience and a trend towards less suffering. Antidepressants did not predict symptom burden or ward experience, except for amitriptyline's inverse relationship with process perception. Discussion: Regarding process perception and therapy outcome, amitriptyline might have unfavorable effects at dose reductions, whereas COX-inhibition could be beneficial at higher dosages. Similar findings have already been described with regard to COX-inhibition in depression and schizophrenia.

[一项关于抗抑郁药(如 SSRI)和乙酰水杨酸(ASA)对住院心身疾病治疗过程中心理治疗自我评价的影响及其结果的自然研究:ASA是否有益?]
目的:精神知觉是心理治疗过程的核心,某些精神药物(包括抗抑郁药和环氧合酶(COX)抑制剂,如乙酰水杨酸(ASA))可改变精神知觉。研究方法我们分析了 208 名参与者的医疗记录,并通过线性回归分析和四次重复测量,利用每周平均用药量和治疗周数来预测病房体验(Stationserfahrungsbogen)和症状负担(症状检查表 90-R)。结果时间可预测症状缓解情况。ASA 表明病房体验更佳,痛苦有减轻的趋势。除了阿米替林与过程感知呈反向关系外,抗抑郁药并不能预测症状负担或病房体验。讨论:关于过程感知和治疗结果,阿米替林在剂量减少时可能会产生不利影响,而COX抑制剂在剂量增加时可能会产生益处。在抑郁症和精神分裂症中,COX抑制剂也有类似的研究结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.50
自引率
11.10%
发文量
30
审稿时长
>12 weeks
期刊介绍: This journal provides a systematic overview of the entire field of psychosomatic medicine. It is also the official organ of the German Society for Psychosomatic Medicine and Medical Psychotherapy (DGPM). It serves as a forum for discussions of the interdisciplinary experiences in the field of psychosomatics, the goal being the furtherance of scientific insights into the interactions between mental and physical factors in the development of disease. It also provides a way to deepen one´s knowledge of psychoanalysis and to explore new therapeutic directions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信